ABL (Y251) Antibody Blocking peptide
ABL (Y251) Antibody Blocking peptide
Product Specifications
Product Name Alternative
Abelson tyrosine-protein kinase , Abelson murine leukemia viral oncogene homolog , ABL1
UniProt
P00519
Field of Research
Apoptotic, Autophagic, Cancer, DNA Damage, Epigenetics, Neuroscience, Signaling Pathways
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the Y251 region of human ABL. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
